Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : International Nursing Services Inc, old (NURS) new (MDIX) -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (600)	4/25/1998 5:41:00 PM
From: Mike Moran	Read Replies (3) \| Respond to of 2911

Everybody is entitled to an opinion in the ADRX/MDIX dispute. There is certainly no shortage. Here's my 2 cents worth based on an evening of conversation I had on a cold, rainy NYC night in March with an analyst for Cowen, a researcher for Pfizer and an IB from Merrill. All four of us had returned from the HIMSS trade show in Orlando, FL. All of us knew of the Cymedix product because we cover SNTC. The number of companies with a chance to impact this market is small. My take on this was simple. I had visited the Cymedix booth at HIMSS. While there I met the former Cymedix Chairman (the guy prior to the merger with MDIX), another Merrill guy. He told me that he had put the two companies together and had expected ADRX to acquire Cymedix. He told me that last summer people from Cymedix told him they didn't trust the ADRX people and were terminating discussions. My Merrill colleague said Cymedix had good reason not to. Not one person at the table that night objected to my comments. Two weeks later MDIX sent the demand letter to ADRX. All the rest since then has been rhetoric. As I said last night, my broker friend in Jersey says that Cymedix has ADRX by the 'nads. I believe him.